RecallDepth
Class II Terminated

Carbidopa and Levodopa Tablets USP, 25mg/100mg, 1000 count bottle, Rx only, Manufactured in Israel by Teva Pharmaceutical IND, LTD., Jeruselem, Israel, for Teva Pharmaceuticals USA, Sellersville, PA, NDC 0093-0293-10

Company
Teva Pharmaceuticals Usa
Recall Initiated
June 5, 2014
Posted
August 20, 2014
Recall Number
D-1538-2014
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
3881bottles
Firm Location
North Wales, PA, United States

Reason for Recall

Failed Tablet/Capsule Specifications: Teva is recalling one lot of Carbidopa and Levodopa Tablets USP, 25mg/100mg due to the potential for superpotent tablets.

Distribution

Nationwide

Lot / Code Info

lot 29C220, Exp. 11/15

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls